Related Experiment Video
Updated: Aug 10, 2025

Synthesis of Masarimycin, a Small Molecule Inhibitor of Gram-Positive Bacterial Growth
Published on: January 7, 2022
Pyrimirhodomyrtone inhibits Staphylococcus aureus by affecting the activity of NagA
Huan Zeng1, Minjing Cheng2, Jingyi Liu3
1Center for Bioactive Natural Molecules and Innovative Drugs Research, Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou 511443, Guangdong, China; Shenzhen Institute of Respiratory Diseases, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen 518020, China.
Abstract:
The epidemic of methicillin-resistant Staphylococcus aureus (MRSA) infections has created a critical health threat. The drug resistance of MRSA makes the development of drugs with new modes of action particularly urgent. In this study, we found that a natural product derivative pyrimirhodomyrtone (PRM) exerted antibacterial activity against S. aureus, including MRSA, both in vitro and in vivo. Genetic and biochemical studies revealed the interaction between PRM and N-acetylglucosamine-6-phosphate deacetylase (NagA) and the inhibitory effect of PRM on its deacetylation activity. We also found that PRM causes depolarization and destroys the integrity of the cell membrane. The elucidation of the antibacterial mechanism will inspire the subsequent development of new anti-MRSA drugs based on PRM.
Insights
Pyrimrhodomyrtone (PRM) shows antibacterial effects against methicillin-resistant Staphylococcus aureus (MRSA). This natural product derivative inhibits the NagA enzyme and disrupts the bacterial cell membrane, offering a new avenue for anti-MRSA drug development.
Area of Science:
- Microbiology and Infectious Diseases
- Natural Product Chemistry
- Drug Discovery and Development
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) infections represent a significant global health challenge due to widespread antibiotic resistance.
- The urgent need for novel therapeutic agents with distinct mechanisms of action against MRSA is paramount.
Purpose of the Study:
- To investigate the antibacterial potential of pyrimrhodomyrtone (PRM), a natural product derivative, against *Staphylococcus aureus*, including MRSA strains.
- To elucidate the molecular mechanism underlying PRM's antibacterial activity.
Main Methods:
- In vitro and in vivo antibacterial assays were performed to evaluate PRM's efficacy.
- Genetic and biochemical techniques were employed to identify PRM's molecular targets and interactions.
- Cell membrane integrity and potential depolarization were assessed.
Main Results:
- PRM demonstrated significant antibacterial activity against *S. aureus* and MRSA isolates.
- PRM was found to interact with and inhibit N-acetylglucosamine-6-phosphate deacetylase (NagA).
- PRM treatment led to bacterial cell membrane depolarization and integrity disruption.
Conclusions:
- Pyrimrhodomyrtone (PRM) is a promising natural product derivative with potent anti-MRSA activity.
- The antibacterial action of PRM involves the inhibition of NagA and damage to the bacterial cell membrane.
- Understanding PRM's mechanism provides a foundation for developing novel anti-MRSA therapeutics.
Related Concept Videos
Gene Regulation in Microbial Communities: Quorum Sensing
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...

